Skip to main content

Temple University

Temple University
Philadelphia, Pennsylvania
SOURCE: SPIROMICS Study of Early COPD Progression is looking for current and former cigarette smokers between 30 and 55 years old to participate in a research study on early signs of lung disease. Most studies of lung disease and Chronic Obstructive Pulmonary Disease (COPD) involve older people. This 5-year study in 12 cities across the U.S. will help us better understand COPD in younger people. You do not need a COPD diagnosis to join.

The SOURCE research study is not yet active in Philadelphia but will begin enrolling participants in Fall 2021. Please check back soon.

Study Site Location

Temple University Hospital
3401 N. Broad Street
Ambulatory Care Center, 5th Floor
Philadelphia, PA 19140

(215) 707-1359 breathe@tuhs.temple.edu
Gerard Criner, MD
Gerard Criner, MD, FACP, FACCP
Principal Investigator
COPD is a devastating disease of significant morbidity and mortality for many patients worldwide. Identifying the origins of COPD is pivotal to help develop novel targets for early treatment to improve patient outcome.
Placeholder
Melissa Liverpool
Clinical Research Coordinator
false

Are you eligible to join?

Current and former cigarette smokers are eligible. No COPD diagnosis is necessary. Answer the screening questions by entering your age and the numbers of years smoked. If you are eligible, you’ll be asked for your contact information. By submitting your contact information you’re agreeing to be contacted about this study.

Individuals between the ages of 30 and 55 who are current or former cigarette smokers may qualify for this study on early COPD.